Simran Asawa

1k citations
13 papers · 778 · 3 hit papers · h-index 8

Impact in

    • Nanoparticle-Based Drug Delivery
    • Electrospun Nanofibers in Biomedical Applications
    • biodegradable polymer synthesis and properties

Papers in

Simran Asawa

12 papers receiving 764 citations

Simran Asawa's Hit Papers

Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial 2025 · 39 citations
390+2+5Years since publication100200300

Peers

Simran Asawa
Comparison fields: 5 of 74
  • Biomaterials 283
  • Drug Discovery 2
  • Biomedical Engineering 242
  • Oncology 99
  • Cancer Research 38
Replace Raviraja Neelavar Seetharam with:
Raviraja Neelavar Seetharam India
Fakhera Ikram Pakistan
Krzysztof Kamocki United States
Qiusheng Shi China
Michelle R. Kreke United States
Joana Vieira de Castro Portugal
Alimohammad Shafiee Australia
Salwa Suliman Norway
Sue Anne Chew United States
Deepak Gupta India
Simran Asawa relative to Raviraja Neelavar Seetharam India Raviraja Neelavar Seetharam's profile →
Citations per field
00.5×1.5×2×2.5×
Raviraja Neelavar Seetharam · 1×
Citations per year

Countries citing papers authored by Simran Asawa

Since Specialization
Citations

This map shows the geographic impact of Simran Asawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Asawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Asawa more than expected).

Fields of papers citing papers by Simran Asawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simran Asawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Asawa. The network helps show where Simran Asawa may publish in the future.

Co-authors

The 25 scholars most cited alongside Simran Asawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simran Asawa Line = papers co-authored together Simran Asawa links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
PCL-Based Composite Scaffold Matrices for Tissue Engineering Applications
Hit paper breakdown →
2018378
2 2017191
3
Progressive plasticity during colorectal cancer metastasis
Hit paper breakdown →
2024111
4
Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial
Hit paper breakdown →
202539
5 202513
6 201812
7 202312
8 202311
9 20185
10 20254
11 20191
12 20231
13 20260

About Simran Asawa

Simran Asawa is a scholar working on Oncology, Biomaterials, Cancer Research, Pharmacology and Food Science, having authored 13 papers that have together received 778 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Essential Oils and Antimicrobial Activity (1 paper), Mitochondrial Function and Pathology (1 paper), Cancer Genomics and Diagnostics (1 paper) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Biomaterials (283 citations), Drug Discovery (2 citations), Biomedical Engineering (242 citations), Oncology (99 citations) and Cancer Research (38 citations). Simran Asawa has collaborated with scholars based in India, Switzerland and United States. Frequent co-authors include Bhaskar Birru, Rama Raju Baadhe, Nadeem Siddiqui, Ashwin Narain, Yogita Patil‐Sen, Nicola Aceto, Abhishek Kumar Dwivedy, Nawal Kishore Dubey, Ana Gvozdenovic and Vipin Kumar Singh. Their work appears in journals such as Nature Medicine, Microbial Biotechnology, eLife, British Journal of Cancer and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact